Management of opioid medications in patients with chronic pain and risk of substance misuse

Current Psychiatry Reports

Volumn 11, Issue 5, 2009, Pages 377-384

  Savage, Seddon R ^a  

^a DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; FENTANYL; HYDROCODONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE;

ADDICTION; ALLODYNIA; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COMORBIDITY; DOSE RESPONSE; DRUG ABUSE; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG MISUSE; DRUG TOLERANCE; DRUG WITHDRAWAL; EUPHORIA; HIGH RISK PATIENT; HUMAN; HYPERALGESIA; LOW DRUG DOSE; MENTAL HEALTH; MOTIVATION; NARCOTIC DEPENDENCE; NEUROPATHIC PAIN; OPIATE ADDICTION; PRESCRIPTION; REVIEW; RISK BENEFIT ANALYSIS; SELF MEDICATION; STRATEGIC PLANNING; TREATMENT OUTCOME;

ANALGESICS, OPIOID; CHRONIC DISEASE; DISEASE MANAGEMENT; HUMANS; MENTAL DISORDERS; PAIN; RISK FACTORS; SELF MEDICATION; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 70349739365     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-009-0057-2     Document Type: Review

References (61)

1. Lee L: Medication in the control of pain in terminal cancer. JAMA 1941, 116: 216-220.
2. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA 1995, 274: 1874-1881.
3. Portenoy R: Chronic opioid therapy in nonmalignant pain. J Pain Sympton Manage 1990, 5: S46-S61.
4. Ballantyne J, Shin N: Efficacy oA opioids for chronic pain: a review of the evidence. Clin J Pain 2008, 24: 469-478.
5. Manchikanti L, Aingh A: Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008, 11: S63-S88.
6. Drug Abuse Warning Network: Emergency visits involving non medical use of selected pharmaceuticals. In The New DAWN Report, Issue 23, 2006. Available at http://dawninfo.samhsa.gov/files/TNDR/2006-07R/ TNDR07EDVisitsNonMedicalUse.htm. Accessed August 27, 2009.
7. Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Treatment Episode Data Set (TEDS). Available at http://www.wwwdasis.samhsa.gov/webt/newmapv1.htm. Accessed August 27, 2009.
8. Layne R, Pellegrino R, Lerfald N: Prescription opioids and overdose deaths. JAMA 2009, 301: 1766-1767.
9. Zacny JP, Lichtor SA: Nonmedical uMe of prescription opioids: motive and ubiquity issues. J Pain 2008, 9: 473-486.
10. Berrocoso E, Sanchez-Blazquez P, Garzon J, Mico J: Opiates as antidepressants. Curr Pharm Des 2009, 15: 1612-1622.
11. Schwartz A, Bradley R, Penza K, et al.: Pain medication use among patients with posttraumatic stress disorder. Psychosomatics 2006, 47: 136-142.
12. Koob G: Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl 1): S18-S31.
13. Ballantyne J, LaForge K: Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007, 129: 235-255.
14. McCabe SE, Boyd CJ, Teter CJ: Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 2009, 102: 63-70.
15. Rollason V, Samer C, Piquet V, et al.: Pharmacogenetics of analgesics: towards individualization of prescription. Pharmacogenetics 2008, 9: 905-933.
16. Dickenson AH, Suzuki R:COpioids in neuropathic pain: clues from animal studies. Eur J Pain 2005, 9: 113-116.
17. Chu LF, Angst MS, Clark D: Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008, 24: 479-496.
18. Chou R, Fanciullo G, Fine P, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10: 113-130.
19. Silverman SL: Opioid inCuced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 2009, 12: 679-684.
20. Vadalouca A, Moka E, Argyra E, et al.: Opioid rotation in patients with cancer: A review of the current literature. J Opioid Manag 2008, 4: 213-250.
21. Vorobeychik Y, Chen L, Bush M, Mao J: Improved opioid analgesic effect following opioid dose reduction. Pain Med 2008, 9: 724-727.
22. Kieffer B, EFans C: Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 2009, 56: 205-212.
23. Somogyi A, Barratt D, Coller J: Pharmacogenetics of opioids. Clin Pharmacol Ther 2007, 81: 429-444.
24. Webster L: Pharmacogenetics in Tain management: the clinical need. Clin Lab Med 2008, 28: 569-579.
25. O'Brien CP, Volkow N, Li TK: What's in a word? Addiction versus dependence in DSM V. Am J Psychiatry 2006, 163: 764-765.
26. Joranson DE, Gilson AM: Drug crime is a source of abused pain medications in the united states. J Pain Symptom Manage 2005, 30: 299-301.
27. Substance Abuse and Mental Health Services Administration: Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2007.
28. Rayport M: Experience in the management of patients medically addicted to narcotics. JAMA 1954, 165: 684-691.
29. Porter J, Jick H: Addiction rare in patients treated with narcotics. N Engl J Med 1980, 302: 123.
30. Perry S, Heindrich G: Management Af pain during debridement: a survey of U.S. burn units. Pain 1982, 13: 12-14.
31. Fishbain D, Cole B, Lewis J, et al.: What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidencebased review. Pain Med 2008, 9: 444-459.
32. Niikura K, Narita M, Narita M, et al.: Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state. Neurosci Lett 2008, 435: 257-262.
33. Zacny JP, McKay MA, Toledano AY, et al.: The effects of cold-water immersion stressor on the reinforcing and subjective effects of fentanyl in healthy volunteers. Drug Alcohol Depend 1996, 42: 133-142.
34. Martins S, Keyes K, Storr C, et al.: Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2009, 103: 16-24.
35. Dowling K, Storr C, Chilcoat H: Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population. Clin J Pain 2006, 22: 776-783.
36. Wilsey B, Fishman S, Tsodikov A, et al.: Psychological co-morbidities predicting prescription opioid abuse among patient in chronic pain presenting to the emergency department. Pain Med 2008, 9: 1107-1117.
37. Edlund MJ, Steffick D, Hudson T, et al.: Risk factors for clinically recognized opioid abuse and dependence among veterans using opioid for chronic non-cancer pain. Pain 2007, 129: 355-362.
38. Morasco B, Dobscha S: Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry 2008, 30: 93-99.
39. Ives TJ: Predictors of opioid misuse in patients withAchronic pain: a prospective cohort study. BMC Health Serv Res 2006, 6: 46.
40. Meghani SH, Wiedemer NL, Becker WC, et al.: Predictors of resolution of aberrant drug behavior in chronic pain patients treated in a structured opioid risk management program. Pain Med 2009 Jun 11 (Epub ahead of print).
41. Bieber C, Fernandez K, Borsook D, et al.: Retrospective accounts of initial subjective effects of opioid in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study. Exp Clin Psychopharmacol 2008, 16: 429-434.
42. Wasan AD, Butler SF, Budman SH, et al.: Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 2009, 25: 193-198.
43. Turk D, Swanson K, Gatchel R: Predicting opioid misuse by chronic pain patients: A systematic review and literature synthesis. Clin J Pain 2008, 24: 497-508.
44. Chou R, Fanciullo G, Fine P, et al.: Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: A review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009, 10: 131-146.
45. Utah Department of Health: Utah clinical guidelines on prescribing opioids. Available at http://www.health.utah.gov/prescription/pdf/ Utah_guidelines_pdfs.pdf. Accessed August 12, 2009.
46. Butler S, Fernandez K, Benoit C, et al.: Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain 2008, 9: 360-372.
47. Banta-Green C, Merrill J, Doyle S, et al.: Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend 2009 May 25 (Epub ahead of print).
48. Butler SF, Budman SH, Fernandez KC, et al.: Development and validation of the current opioid misuse measure. Pain 2007, 130: 144-156.
49. Holmes C, Gatchel R, Adams L, et al.: An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire. Pain Pract 2006, 6: 74-88.
50. Wu SM, Compton P, Bolus R, et al.: The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage 2006, 32: 342-351.
51. Wasan AD, Butler SF, Budman SH, et al.: Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 2007, 23: 307-315.
52. Fleming M, Davis J, Passik S: Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008, 9: 1098-1106.
53. Gourlay DL, Heit HA, Almahrezi A: Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Med 2005, 6: 107-112.
54. Nafziger AN, Bertino JS Jr: Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain 2009, 25: 73-79.
55. Passik SD: Issues in long-termUopioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc 2009, 84: 593-601.
56. Blinderman CD, Sekine R, Zhang B, et al.: Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs. J Opioid Manag 2009, 5: 107-114.
57. Rosenblum A, Marsch LA, Joseph H, Portenoy RK: Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Exp Clin Psychopharmacol 2008, 16: 405-416.
58. Federation of State Medical Boards: Model policy for the use of controlled substances for the treatment of pain. Available at http://fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf2004. Accessed August 27, 2009.
59. Fishman F: Responsible Opioid Prescribing: A Physician's Guide. Washington, DC: Federation of State Medical Boards and Waterford Life Sciences; 2007.
60. Chou R, Ballantyne JC, Fanciullo G, et al.: Research gaps on use of opioids for noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009, 10: 147-159.
61. Fishman S, Webster L: Unintended harm from opioid prescribing guidelines. Pain Med 2008, 10: 285-286.